These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 28843783)

  • 21. Granulocyte colony-stimulating factor priming improves embryos and pregnancy rate in patients with poor ovarian reserve: a randomized controlled trial.
    Jinno M; Tamaoka Y; Teruya K; Watanabe A; Hatakeyama N; Goda T; Kimata H; Jinno Y
    Reprod Biol Endocrinol; 2023 Mar; 21(1):29. PubMed ID: 36944952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study.
    Papaleo E; Zaffagnini S; Munaretto M; Vanni VS; Rebonato G; Grisendi V; Di Paola R; La Marca A
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():94-99. PubMed ID: 27835829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles.
    La Marca A; Minasi MG; Sighinolfi G; Greco P; Argento C; Grisendi V; Fiorentino F; Greco E
    Fertil Steril; 2017 Nov; 108(5):777-783.e2. PubMed ID: 28987789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of serum Anti-Mullerian Hormone levels on the results of assisted reproductive technologies. Single-center retrospective study from 2011 cycles (ICSI and bilateral tubal obstruction excluded)].
    Dosso N; Robin G; Catteau-Jonard S; Pigny P; Leroy-Billiard M; Dewailly D
    J Gynecol Obstet Biol Reprod (Paris); 2015 Jan; 44(1):63-71. PubMed ID: 24951378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
    Polyzos NP; Nelson SM; Stoop D; Nwoye M; Humaidan P; Anckaert E; Devroey P; Tournaye H
    Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.
    Guo Y; Liu S; Hu S; Li F; Jin L
    Front Endocrinol (Lausanne); 2021; 12():673284. PubMed ID: 34122349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMH type II receptor and AMH gene polymorphisms are not associated with ovarian reserve, response, or outcomes in ovarian stimulation.
    Cerra C; Newman WG; Tohlob D; Byers H; Horne G; Roberts SA; Mohiyiddeen L
    J Assist Reprod Genet; 2016 Aug; 33(8):1085-91. PubMed ID: 27142041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?
    Wang S; Zhang Y; Mensah V; Huber WJ; Huang YT; Alvero R
    J Ovarian Res; 2018 Jul; 11(1):60. PubMed ID: 30012195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Apr; 69(2):128-134. PubMed ID: 27310675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of Ding-Kun-Dan for female infertility patients with predicted poor ovarian response undergoing in vitro fertilization/intracytoplasmic sperm injection: study protocol for a randomized controlled trial.
    Ma S; Ma R; Xia T; Afnan M; Song X; Xu F; Hao G; Zhu F; Han J; Zhao Z
    Trials; 2018 Feb; 19(1):124. PubMed ID: 29458401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
    Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
    Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective study of ovarian reaction and fertility in women with discordant antimullerian hormone and follicle-stimulating hormone/luteinizing hormone ratios during in vitro fertilization.
    Wang J; Lv Y; Wang X; Zhu G; Zhao F
    J Obstet Gynaecol Res; 2023 Mar; 49(3):966-972. PubMed ID: 36734373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the anti-Müllerian hormone truly reflect ovarian response in women with endometrioma?
    Inal ZO; Engin Ustun Y; Yilmaz N; Aktulay A; Bardakci Y; Gulerman C
    J Obstet Gynaecol; 2019 May; 39(4):516-521. PubMed ID: 30744464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of anti-Müllerian hormone and age in predicting pregnancy outcomes of in vitro fertilization and embryo transfer treatment].
    Chen YH; Wang Q; Zhang YN; Xu XH; Lu J; Zhang SD; Zhang CL
    Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):239-244. PubMed ID: 31006189
    [No Abstract]   [Full Text] [Related]  

  • 35. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.
    Andersen AN; Witjes H; Gordon K; Mannaerts B;
    Hum Reprod; 2011 Dec; 26(12):3413-23. PubMed ID: 21954280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro fertilization outcomes after ablation of endometriomas using plasma energy: A retrospective case-control study.
    Motte I; Roman H; Clavier B; Jumeau F; Chanavaz-Lacheray I; Letailleur M; Darwish B; Rives N
    Gynecol Obstet Fertil; 2016 Oct; 44(10):541-547. PubMed ID: 27665252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High anti-Müllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF/ICSI treatment.
    Sun TC; Zhou SJ; Song LL; Li JH; Chen X; Tian L
    JBRA Assist Reprod; 2021 Apr; 25(2):266-271. PubMed ID: 33710839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance of anti-Mullerian hormone measurement in a routine IVF program.
    Gnoth C; Schuring AN; Friol K; Tigges J; Mallmann P; Godehardt E
    Hum Reprod; 2008 Jun; 23(6):1359-65. PubMed ID: 18387961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High live birth rate in the subsequent IVF cycle after first-cycle poor response among women with mean age 35 and normal FSH.
    Moolenaar LM; Mohiuddin S; Munro Davie M; Merrilees MA; Broekmans FJ; Mol BW; Johnson NP
    Reprod Biomed Online; 2013 Oct; 27(4):362-6. PubMed ID: 23953583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between Ovarian Reserve and Incidence of Ectopic Pregnancy after
    Kim SW; Kim YJ; Shin JH; Kim H; Ku SY; Suh CS; Kim SH; Choi YM
    Yonsei Med J; 2019 Mar; 60(3):285-290. PubMed ID: 30799591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.